ID: ALA552617
Chembl Id: CHEMBL552617
PubChem CID: 45260665
Max Phase: Preclinical
Molecular Formula: C15H21Cl2N3O
Molecular Weight: 257.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cl.Cl.N[C@@H](Cc1c[nH]cn1)C(=O)CCCc1ccccc1
Standard InChI: InChI=1S/C15H19N3O.2ClH/c16-14(9-13-10-17-11-18-13)15(19)8-4-7-12-5-2-1-3-6-12;;/h1-3,5-6,10-11,14H,4,7-9,16H2,(H,17,18);2*1H/t14-;;/m0../s1
Standard InChI Key: MVSZKNBVSXBOIP-UTLKBRERSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 257.34 | Molecular Weight (Monoisotopic): 257.1528 | AlogP: 1.87 | #Rotatable Bonds: 7 |
| Polar Surface Area: 71.77 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
| #RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
| CX Acidic pKa: 13.09 | CX Basic pKa: 7.55 | CX LogP: 2.04 | CX LogD: 1.65 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.80 | Np Likeness Score: 0.01 |
| 1. Dancer JE, Ford MJ, Hamilton K, Kilkelly M, Lindell SD, O'Mahony MJ, Saville-Stones EA. (1996) Synthesis of potent inhibitors of histidinol dehydrogenase, 6 (17): [10.1016/0960-894X(96)00384-8] |
Source(1):
